Sei Investments Co. Sells 6,723 Shares of Encompass Health Co. (NYSE:EHC)

Sei Investments Co. lowered its position in Encompass Health Co. (NYSE:EHC) by 3.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 220,599 shares of the company’s stock after selling 6,723 shares during the period. Sei Investments Co. owned 0.22% of Encompass Health worth $20,373,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of EHC. MassMutual Private Wealth & Trust FSB raised its position in Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after purchasing an additional 137 shares during the last quarter. CBIZ Investment Advisory Services LLC increased its stake in shares of Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock valued at $42,000 after buying an additional 127 shares in the last quarter. Tompkins Financial Corp bought a new position in shares of Encompass Health in the fourth quarter valued at about $46,000. V Square Quantitative Management LLC lifted its position in Encompass Health by 43.8% during the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock worth $54,000 after buying an additional 177 shares in the last quarter. Finally, Morse Asset Management Inc bought a new stake in Encompass Health during the 3rd quarter worth about $68,000. 97.25% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, CAO Andrew L. Price sold 5,042 shares of the firm’s stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares of the company’s stock, valued at $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 2.10% of the company’s stock.

Encompass Health Price Performance

Shares of EHC opened at $101.19 on Friday. The stock has a market cap of $10.19 billion, a P/E ratio of 22.69, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92. Encompass Health Co. has a 1 year low of $78.53 and a 1 year high of $104.55. The stock’s 50-day moving average price is $98.55 and its two-hundred day moving average price is $97.31. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. On average, equities analysts predict that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.67%. The ex-dividend date is Tuesday, April 1st. Encompass Health’s payout ratio is presently 15.25%.

Analyst Ratings Changes

A number of equities analysts have weighed in on the stock. StockNews.com raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, February 15th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $110.00 price objective on shares of Encompass Health in a report on Tuesday, February 11th. William Blair reiterated an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. Barclays boosted their target price on Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, February 7th. Finally, KeyCorp raised their price target on Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a report on Monday, February 10th. Ten investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $107.67.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.